TopoGEN scientists have developed a novel solid phase screening assay suitable for High Throughput Screening. This method has the ability to unambiguously identify topoisomerase targeting drugs. In addition, this HTS method will predict if a test drug is an INTERFACIAL POISON or a CATALYTIC INHIBITOR. Stay tuned for more details! The paper has been submitted for publication and will be released on this blog. In the meantime feel free to contact us with any questions about this exciting new development.